Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:BIAF

bioAffinity Technologies (BIAF) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free BIAF Stock Alerts
$2.26
-0.19 (-7.76%)
(As of 05/17/2024 08:53 PM ET)
Compare
Today's Range
$2.18
▼
$2.60
50-Day Range
$1.77
▼
$3.00
52-Week Range
$0.95
▼
$3.62
Volume
132,200 shs
Average Volume
172,328 shs
Market Capitalization
$26.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media
BIAF stock logo

About bioAffinity Technologies Stock (NASDAQ:BIAF)

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

BIAF Stock Price History

BIAF Stock News Headlines

May 15, 2024 | msn.com
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024
May 15, 2024 | businesswire.com
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 2, 2024 | businesswire.com
bioAffinity Technologies News Update
April 26, 2024 | investing.com
bioAffinity Technologies appoints VP to enhance diagnostics
April 24, 2024 | businesswire.com
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 9, 2024 | finance.yahoo.com
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 9, 2024 | businesswire.com
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
March 8, 2024 | finance.yahoo.com
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 8, 2024 | finance.yahoo.com
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 6, 2024 | msn.com
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
March 6, 2024 | marketwatch.com
BioAffinity Technologies Shares Plummet After Stock Sale
March 6, 2024 | msn.com
Why BioAffinity Technologies (BIAF) Shares Are Down 50%
March 6, 2024 | msn.com
BioAffinity Technologies to raise $2.5M from stock offering and private placement
March 6, 2024 | finance.yahoo.com
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 6, 2024 | businesswire.com
bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 1, 2024 | finance.yahoo.com
Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
February 21, 2024 | finance.yahoo.com
bioAffinity Technologies News Update
February 21, 2024 | businesswire.com
bioAffinity Technologies News Update
February 6, 2024 | finance.yahoo.com
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice
January 23, 2024 | finance.yahoo.com
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
January 8, 2024 | finance.yahoo.com
bioAffinity Technologies In the News
November 30, 2023 | marketwatch.com
BioAffinity Shares Rise on Addition to Government Pay Schedule
November 30, 2023 | finance.yahoo.com
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
November 15, 2023 | finance.yahoo.com
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
November 14, 2023 | finance.yahoo.com
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
See More Headlines

Company Calendar

Last Earnings
4/01/2024
Today
5/19/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIAF
CUSIP
N/A
CIK
1712762
Web
www.bioaffinitytech.com
Phone
210-698-5334
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,940,000.00
Net Margins
-171.43%
Pretax Margin
-169.16%
Return on Equity
-134.34%
Return on Assets
-95.83%

Debt

Debt-to-Equity Ratio
0.14
Current Ratio
2.22
Quick Ratio
1.76

Sales & Book Value

Annual Sales
$2.53 million
Price / Sales
10.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
5.02

Miscellaneous

Outstanding Shares
11,660,000
Free Float
7,410,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
3.15

Key Executives

  • Mr. Steven Girgenti (Age 78)
    Founder & Executive Chairman of the Board
    Comp: $113.75k
  • Ms. Maria Zannes J.D. (Age 68)
    Founder, President, CEO & Director
    Comp: $299.17k
  • Ms. Julie Anne Overton
    Director of Communications
  • Mr. Dallas J. Coleman
    National Director of Sales
  • Dr. William Bauta Ph.D.
    Senior Vice President of Therapeutics

Key Competitors

View All Competitors

BIAF Stock Analysis - Frequently Asked Questions

How have BIAF shares performed in 2024?

bioAffinity Technologies' stock was trading at $1.4705 at the start of the year. Since then, BIAF stock has increased by 53.7% and is now trading at $2.26.
View the best growth stocks for 2024 here.

When is bioAffinity Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our BIAF earnings forecast.

How were bioAffinity Technologies' earnings last quarter?

bioAffinity Technologies, Inc. (NASDAQ:BIAF) released its quarterly earnings data on Monday, April, 1st. The company reported ($0.26) EPS for the quarter. The firm earned $2.21 million during the quarter. bioAffinity Technologies had a negative net margin of 171.43% and a negative trailing twelve-month return on equity of 134.34%.

When did bioAffinity Technologies IPO?

bioAffinity Technologies (BIAF) raised $8 million in an IPO on Thursday, September 1st 2022. The company issued 1,300,000 shares at a price of $6.00-$6.25 per share. WallachBeth Capital served as the underwriter for the IPO and Craft Capital Management was co-manager.

How do I buy shares of bioAffinity Technologies?

Shares of BIAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIAF) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Urgent Nvidia Warning
Altimetry
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Global crypto currency reset (41 major banks signed up)
Stansberry Research
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders